Clinical Trial

Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated March 8, 2023 (before its estimated March 7, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a phase II study that will examine the immunogenicity of the Shingrix vaccine in patients following an allogeneic stem cell transplant.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-09-21.
Status change: Not Yet Recruiting → Recruiting 2023-03-07
Trial Details
NCT Number NCT05554068
Lead Sponsor Loyola University
Conditions Shingles
Enrollment 100 participants
Start Date 2023-03-07
Primary Completion 2025-03-07 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2023-03-08